Abstract:The clinical application of technological progress in the identification of DNA alterations has always led to improvements of diagnostic yields in genetic medicine. At chromosome side, from cytogenetic techniques evaluating number and gross structural defects to genomic microarrays detecting cryptic copy number variants, and at molecular level, from Sanger method studying the nucleotide sequence of single genes to the high-throughput next-generation sequencing (NGS) technologies, resolution and sensitivity progressively increased expanding considerably the range of detectable DNA anomalies and alongside of Mendelian disorders with known genetic causes. However, particular genomic regions (i.e., repetitive and GC-rich sequences) are inefficiently analyzed by standard genetic tests, still relying on laborious, time-consuming and low-sensitive approaches (i.e., southern-blot for repeat expansion or long-PCR for genes with highly homologous pseudogenes), accounting for at least part of the patients with undiagnosed genetic disorders. Third generation sequencing, generating long reads with improved mappability, is more suitable for the detection of structural alterations and defects in hardly accessible genomic regions. Although recently implemented and not yet clinically available, long read sequencing (LRS) technologies have already shown their potential in genetic medicine research that might greatly impact on diagnostic yield and reporting times, through their translation to clinical settings. The main investigated LRS application concerns the identification of structural variants and repeat expansions, probably because techniques for their detection have not evolved as rapidly as those dedicated to single nucleotide variants (SNV) identification: gold standard analyses are karyotyping and microarrays for balanced and unbalanced chromosome rearrangements, respectively, and southern blot and repeat-primed PCR for the amplification and sizing of expanded alleles, impaired by limited resolution and sensitivity that have not been significantly improved by the advent of NGS. Nevertheless, more recently, with the increased accuracy provided by the latest product releases, LRS has been tested also for SNV detection, especially in genes with highly homologous pseudogenes and for haplotype reconstruction to assess the parental origin of alleles with de novo pathogenic variants. We provide a review of relevant recent scientific papers exploring LRS potential in the diagnosis of genetic diseases and its potential future applications in routine genetic testing.

Improving Genetic Diagnosis of Mendelian Disease with RNA Sequencing: a Narrative Review

Application of RNA Sequencing in Clinical Diagnosis of Mendelian Disease

Systematic evaluation of the two main blood-based RNA-seq approaches for Mendelian disease diagnosis

[A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (3) - Data analysis].

Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease

Identification of diagnostic candidates in Mendelian disorders using an RNA sequencing-centric approach

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Improving genetic diagnosis in Mendelian disease with transcriptome sequencing

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing

RNA Sequencing in Disease Diagnosis

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Clinical validation of RNA sequencing for Mendelian disorder diagnostics

Emerging technologies for prenatal diagnosis: The application of whole genome and RNA sequencing

Targeted Next-Generation Sequencing As a Comprehensive Test for Mendelian Diseases: a Cohort Diagnostic Study.

RNA Sequencing Facilitates the Identification of Genetic Causes of Duchenne Muscular Dystrophy and Proposes a Stepwise DMD Diagnostic Procedure

Analysis of transcript-deleterious variants in Mendelian disorders: implications for RNA-based diagnostics

Using Next-Generation Sequencing As A Genetic Diagnostic Tool in Rare Autosomal Recessive Neurologic Mendelian Disorders

Application of Next Generation Sequencing Technology in Mendelian Movement Disorders

Long read sequencing on its way to the routine diagnostics of genetic diseases

Whole Genome Sequencing and Its Applications in Medical Genetics